Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transradial access versus transfemoral access: a comparison of outcomes and efficacy in reducing hemorrhagic events.
Cesaro A, Moscarella E, Gragnano F, Perrotta R, Diana V, Pariggiano I, Concilio C, Alfieri A, Cesaro F, Mercone G, Falato S, Esposito A, Di Girolamo D, Limongelli G, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Expert Rev Cardiovasc Ther. 2019 Jun;17(6):435-447. doi: 10.1080/14779072.2019.1627873. Expert Rev Cardiovasc Ther. 2019. PMID: 31213156 Review.
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
Costa F, Vranckx P, Leonardi S, Moscarella E, Ando G, Calabro P, Oreto G, Zijlstra F, Valgimigli M. Costa F, et al. Among authors: moscarella e. Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25. Eur Heart J. 2015. PMID: 25718355 Clinical Trial.
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.
Moscarella E, Varricchio A, Stabile E, Latib A, Ielasi A, Tespili M, Cortese B, Calabrò P, Granata F, Panoulas VF, Franzone A, Trimarco B, Bonzani G, Esposito G, Colombo A. Moscarella E, et al. Int J Cardiol. 2015 Nov 15;199:366-72. doi: 10.1016/j.ijcard.2015.07.002. Epub 2015 Jul 11. Int J Cardiol. 2015. PMID: 26241643
Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).
Cortese B, Ielasi A, Moscarella E, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Varricchio A, Tespili M, Latini RA, Defilippi G, Corrado D, Steffenino G; RAI Investigators. Cortese B, et al. Among authors: moscarella e. Am J Cardiol. 2017 Jun 15;119(12):1924-1930. doi: 10.1016/j.amjcard.2017.03.017. Epub 2017 Mar 29. Am J Cardiol. 2017. PMID: 28438304 Clinical Trial.
One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry).
Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Tespili M, Orrego PS, Corrado D, Steffenino G. Ielasi A, et al. Among authors: moscarella e. EuroIntervention. 2018 Aug 3;14(5):e546-e553. doi: 10.4244/EIJ-D-17-00443. EuroIntervention. 2018. PMID: 28966155 Free article.
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study).
Moscarella E, Tanaka A, Ielasi A, Cortese B, Coscarelli S, De Angelis MC, Piraino D, Latib A, Grigis G, Bianchi R, Buccheri D, Calabrò P, Tespili M, Silva Orrego P, Colombo A, Varricchio A. Moscarella E, et al. Catheter Cardiovasc Interv. 2018 Oct 1;92(4):668-677. doi: 10.1002/ccd.27473. Epub 2018 Jan 22. Catheter Cardiovasc Interv. 2018. PMID: 29356269
Functional assessment of coronary stenosis: an overview of available techniques. Is quantitative flow ratio a step to the future?
Cesaro A, Gragnano F, Di Girolamo D, Moscarella E, Diana V, Pariggiano I, Alfieri A, Perrotta R, Golino P, Cesaro F, Mercone G, Campo G, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Expert Rev Cardiovasc Ther. 2018 Dec;16(12):951-962. doi: 10.1080/14779072.2018.1540303. Epub 2018 Nov 1. Expert Rev Cardiovasc Ther. 2018. PMID: 30352515 Review.
Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk.
Cesaro A, Gragnano F, Fimiani F, Moscarella E, Diana V, Pariggiano I, Concilio C, Natale F, Limongelli G, Bossone E, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Eur J Prev Cardiol. 2020 Mar;27(5):556-558. doi: 10.1177/2047487319839179. Epub 2019 Mar 26. Eur J Prev Cardiol. 2020. PMID: 30913901 No abstract available.
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
Moscarella E, Ielasi A, Beneduce A, Ferrante G, Pivato CA, Chiarito M, Cappelletti A, Perfetti G, Magni V, Prati E, Falcone S, Pierri A, De Martini S, Montorfano M, Parisi R, Rutigliano D, Locuratolo N, Anzuini A, Calabrò P, Tespili M, Margonato A, Benassi A, Briguori C, Fabbiocchi F, Reimers B, Bartorelli A, Colombo A, Godino C. Moscarella E, et al. Catheter Cardiovasc Interv. 2019 Dec 1;94(7):972-979. doi: 10.1002/ccd.28305. Epub 2019 Apr 29. Catheter Cardiovasc Interv. 2019. PMID: 31037840
375 results